Skip to main content

Prognostic value of NPR and CLR-based nomogram modeling in elderly patients with Acinetobacter baumannii bloodstream infection

Abstract

Background

Acinetobacter baumannii (A. baumannii) is one of the main pathogens that causesbloodstream infection (BSI) in elderly patients, with high morbidity and mortality rates once infected; new inflammatory indicators, such as the neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio(PLR), have been proposed in recent years, and the prognostic effects of these new inflammatory indicators have not yet been adequately investigated in A.baumannii BSI in elderly patients. Therefore, we verified the effects of these inflammatory indicators on A.baumannii BSIprognosis in elderly patients by constructing a nomogram model.

Methods

The clinical data of 126 elderly patients with A. baumannii BSIwere retrospectively analyzed, and they were divided into a survival group (87 patients) and a death group (39 patients) according to survival status 28 days after infection. Variables were screened by univariate Cox regression analysis and LASSO regression, respectively, and different prognostic models were constructed, and the final models were screened by cross-validation and other means, and the performance of the final models, such as differentiation, was evaluated. Finally, 47 exceptions of data were used to validate the prognostic model of A.baumanniiBSI in elderly patients.

Results

Out of 126 patients, 39 died, for a mortality rate of 31.0%. A high neutrophil–plateletratio(NPR)(hazard ratio [HR] of 35.948,95% confidence interval [CI], 6.890–187.548) and a high C-reactive protein (CRP)-to-lymphocyte ratio (CLR) (HR,1.004;95% CI, 1.002–1.006) are independent risk factors for death in elderly patients with A. baumannii BSI. The model constructed by LASSO regression screening variables avoided the overfitting situation of the model and performed better overall and was considered as the final model.In the final model, the nomogram model predicted the highest discriminatory 7-day prognosis of A. baumanniiBSI in elderly patients, with an area under the working curve (AUC) of 0.821 for subjects, 0.777 and 0.783 for 14 and 28 days, respectively, and a standardized model with good agreement; The clinical decision curve revealed that the model provided good net benefit, ranging from 20 to 100%.

Conclusion

The NPR and CLR are closely associated with the prognosis of A. baumanniiBSI in elderly patients, and in clinical practice, a focus should be placed on these new indicators of inflammation, especially the NPR and CLR, to help physicians better assess the prognosis of A. baumanniiBSI in elderly patients and to develop a more effective therapeutic regimen to improve the survival rate of patients.

Peer Review reports

Background

The aim of this study was to investigate the predictors of overall survival in elderly patients with A. baumanniiBSI. BSI is an important infectious disease that affects the prognosis of infection in hospitalized patients, and elderly patients are at high risk of bacterial BSI due to their own characteristics, such as frequent comorbidities of multiple underlying diseases, mobility problems, and low immunity [12]. A. baumannii is the main pathogen that causes BSI in elderly patients, according to the China Antimicrobial Resistance Surveillance System [3,4,5]. In clinical practice, the widespread presence of A. baumannii and its multiresistant bacteria poses a great challenge to antimicrobial therapy, and the morbidity and mortality rates of elderly patients can reach 56.3% once A. baumanniiBSI occurs [6]. Timely and accurate etiologic diagnosis as well as early and appropriate antimicrobial therapy are important factors affecting the prognosis of patients with A. baumanniiBSI.

New inflammatory indices, such as the systemic immune inflammatory index (SII), NLR, and PLR, have been developed. are new indices proposed in recent years, and the prognostic role of these new inflammatory indices in A. baumanniiBSI in elderly patients has not yet been fully investigated. Understanding the relationships among the NPR, CLR, and overall survival in this population could help clinicians identify high-risk patients and adjust treatment strategies accordingly.

To address this gap in knowledge, this study used Cox regression analysis and construction of a nomogram to investigate the predictive value of the NPR and CLR in elderly patients with A. baumannii bacteremia. By examining the relationships among the NPR, CLR, and overall survival in elderly patients with A. baumanniiBSIs, this study aims to provide valuable insights into the prognostic factors of this challenging clinical condition. Ultimately, the results of this study will contribute to the development of personalized treatment strategies to improve the prognosis of elderly patients with A. baumanniiBSI.

Methods

Study design and patient data

The demographic data and clinical data related to patients diagnosed with A.baumanniiBSI admitted to the ward of Guangdong Provincial Second Hospital of Traditional Chinese Medicine for 13 consecutive years from January 2011 to December 2023 were collected from 126 patients. The case inclusion criteria were as follows: patients diagnosed with A. baumanniiBSI, complete overall survival data and inflammation data, and patients aged 65 years or older at the time of diagnosis of A. baumanniiBSI. If patients presented with multiple blood culture isolates of A. baumannii, the data were taken at the time of the first positivity.

The inclusion criteria were as follows:

  1. 1.

    Patients diagnosed with A. baumannii BSI: (1)Meet the clinical diagnostic requirements for bloodstream infection: fever > 38 °C or hypothermia < 36 °C, which may be accompanied by chills, and combined with one of the following conditions: Invasive portal vein lesions or migrating lesions; Systemic signs of toxicity without obvious foci of infection; Skin rash or haemorrhagic spots, hepatosplenomegaly, blood neutrophilia with left shift of nuclei that cannot be explained by any other cause; Systolic blood pressure less than 12 kPa (90mmHg) or a decrease of more than 5.3 kPa (40mmHg) from the original systolic blood pressure; (2) Positive blood culture with isolation of A.baumannii.

  2. 2.

    Be 65 years of age or older at the time of diagnosis of A. baumannii BSI.

  3. 3.

    Have complete overall survival data and inflammation data, or if the patient has multiple A. baumannii isolated from blood culture, the data at the time of the first positivity.

A total of 126 patients, 82 males (65.1%), with a median age of 80 years, were categorized into 87 patients in the survival group and 39 patients in the death group on the basis of 28-day survival. (Fig. 1)

Fig. 1
figure 1

Study design: patients ≥ 65 years of age with A.baumanniiBSI

Additionally, clinical data of 27 patients with A.baumannii BSI admitted to Guangzhou Xinhai Hospital and 20 patients admitted to the Guangzhou Twelfth People’s Hospital were collected as an external validation dataset.

Definitions of feature variables

Leukocyte counts, neutrophil values, lymphocyte values, monocyte values, platelet counts, C-reactive protein levels, and serum albumin levels were collected from the patient’s hospitalization system and from the laboratory information system for blood analyses on the day of the infection or during a 24-hour period via a self-designed form. The systemic immune inflammation index (SII) was calculated from the above information: platelet count × neutrophil count/lymphocyte count, neutrophil‒lymphocyte ratio (NLR), platelet‒lymphocyte ratio (PLR), lymphomonocyte ratio (LMR), neutrophil–platelet ratio(NPR), platelet‒albumin ratio (PAR), neutrophil‒albumin ratio (NPAR), C-reactive protein‒albumin ratio (CAR), CRP‒lymphocyte ratio (CLR), C-reactive protein-albumin-lymphocyte index (CALLY index): albumin × lymphocyte ÷ (CRP × 10).

Data analysis

The data were analyzed, and models were constructed via R software (version 4.3.1). The dataset collected from the Guangzhou Xinhai Hospital and Guangzhou Twelfth People’s Hospital served as the testcohort.The training cohort dataset, collected from the Guangdong Provincial Second Hospital of Traditional Chinese Medicine, was used to develop the model. The 10 calculated inflammation indices conformed to a normal distribution and were expressed as x ± s, and an independent samples t test was used to compare the two groups. The nonnormal distribution was expressed as the median (quartile) [M (P25, P75)], and a nonparametric rank-sum test was used to compare the groups. P < 0.05 was considered statistically significant, and the meaningful independent variables in the one-way analysis were filtered into the multifactorial regression analysis by Cox, and the related factors affecting the prognosis were screened.

Univariate Cox regression was performed on each of the 10 variables, screening for variables with P < 0.05. A Cox model fit to the variables that passed this screening criterion was referred to as model 1.Separately, LASSO regression was performed on the 10 variables, using a penalty term selected via cross-validation. The LASSO approach to variable selection was referred to as model 2. Models constructed by the two methods were evaluated by comparing predictive performance for the primary 28-day mortality endpoint in a 5-fold cross-validation procedure with 3 repeats in the training set. Performance metrics estimated via cross-validation included area under the receiver operating curve (AUC), root mean squared error (RMSE), and mean absolute error (MAE). The model with the best performance was selected as the final modeling strategy, and was fit to the entire training dataset. This model was evaluated using AUC, calibration curves and clinical decision curve analysis (DCA) in the validation set.

Finally, Nomogram were constructed for the final model, and the model was evaluated with area under ROC curve (AUC), calibration curves, and clinical decision curve analysis (DCA).

Results

Results of Cox regression analysis of the two groups

One-way Cox regression analysis of the variables in the two groups revealed that statistically significant risk factors for A. baumanniiBSI in elderly patients were elevated SII, NLR, NPR, NPAR, CAR, and CLR at the time of infection as well as decreased CALLY and LMR. However, the PLR and PAR were not significantly different. Inflammation indicators such as the SII, NLR, and NPR, with P < 0.05 in the univariate analysis, were included in the multivariate Cox regression analysis, and the results revealed that the NPR and CLR were independent risk factors for death in elderly patients with A. baumanniiBSI (Table 1). A multivariable, unpenalized model was fitted to the univariate Cox regression with P < 0.05 and regarded as model 1, containing the variables SII, NLR, LMR, NPR, NPAR, CAR, CLR and CALLY.

Table 1 Results of the Cox regression

LASSO regression screening variables

Because of the small amount of data and to avoid covariance and overfitting, we used LASSO regression to validate the model variable screening for the multifactor cox regression analysis. The folds of 10 cross-validations were selected for the 10 new inflammatory conditions in the data, such as the SII, NLR, PLR, LMR, NPR, PAR, NPAR, CAR, CLR and CALLY, for LASSO regression analysis. The paths of the LASSO regression coefficients and cross-validations are shown in Fig.  2. The cross-validated errors are within one standard error of the minimum value of the most regularized and most plausible model, which contains 2 variables: NPR and CLR.

Fig. 2
figure 2

LASSO regression. A LASSO regression cross-validation plot; B LASSO regression coefficient path plot

Constructing the prediction model2

According to the results of the LASSO regression analysis, model2 was constructed using the variables NPR and CLR. The coefficients are shown in the following Table 2.

Table 2 The coefficients of Lasso regression analysis

Comparison of the performance of the two models

Using Repeated k-fold Cross Validation (K = 5, replicates = 3) for the two models, Model 1 has an R-squared of 0.122, an RMSE of 0.527, and an MAE of 0.396; Model 2 has an R-squared of 0.180, an RMSE of 0.432, and an MAE of 0.371. MAE was 0.371. Comparing the two models, in the original training set, model 1 has an AUC of 0.779, an R-squaredof 0.212, an RMSE of 0.410, and an MAE of 0.345. Model 2 has an AUC of 0.783, an R-squaredof 0.186, an RMSE of 0.417, and an MAE of 0.357.

In the original training set, the two models are close to each other in terms of their AUCs but model 1 outperforms model 2 in terms of goodness-of-fit and mean error. However, the cross-validation results showed that the goodness of fit of model 2 by LASSO regression was higher than that of model 1, and the RMSE and MAE showed that the average error between the predicted results and the actual observations of model 2 was smaller than that of model 1, which avoided the overfitting situation of the model, and model 2 wasregarded as the final model.

Construction of the model nomogram

The final model was used to construct a predictive model of A. baumanniiBSI in elderly patients via R software to construct a nomogram; Meanwhile, we estimated the Spearman correlation coefficient between NPR and CLR, and the result shows 0.291 (P < 0.001) which indicates that there is a significant positive correlation between them.the model revealed that the model scores NPR and CLR were positively correlated and that the survival rate of the patients decreased as the NPR and CLR increased (Fig. 3).

Fig. 3
figure 3

Nomogram prediction model. NPR, neutrophil–platelet ratio; CLR, C-reactive protein–lymphocyte ratio

Model evaluation

The Bootstrap, ROC curves, calibration curves, and clinical decision curves of the models were plotted separately via R.

Bootstrap resampling internal validation

We performed bootstrap 1000 resampling of the model for internal validation. The resampling results show that the Bootstrap statistic is stable, the bootstrap bias is low (bias = 0.002), the c_index is 0.743, and the model has good results in internal validation (Fig. 4).

Fig. 4
figure 4

Bootstrap results

The AUC and calibration curves are compared at different time points to measure the accuracy and stability of the model

The ROC curves revealed that the model had the highest discriminatory ability for survival at 7 days, with an AUC of 0.821, and the AUCs were 0.777 and 0.783 at 14 and 28 days, respectively.We performed bootstrap 1000 resampling of the training data and the results showed CI for AUC statistic:0.763, 95% 0.674–0.853.

In the test cohort, the AUC values of the model at 7, 14, and 28 days were 0.886, 0.874, and 0.886, respectively.The AUCs suggesting that the model had good discriminatory ability for survival at all 28 days (Fig. 5).

Fig. 5
figure 5

A. ROC curves for different survival times in training cohort; B. ROC curves at 28 days for different variables in training cohort; C. ROC curves for different survival times in test colony; D. ROC curves at 28 days for different variables in test cohort.AUC: areaunder the curve; NPR: neutrophil–platelet ratio; CLR: C-reactive protein–lymphocyte ratio

The calibration curves show that the 7-day, 14-day, and 28-day calibration curves are all at a 45-degree angle in both the training and test cohort, indicating that the prediction model has good calibration capability (Fig. 6).

Fig. 6
figure 6

A. Calibration curves for different survival time models in training colony. B. Calibration curves for different survival time models in test colony. OS: overall survival

DCA curves to assess the value of predictive modelling in clinical decision making.

The clinical decision curves revealed that the decision curves at all three time points of the model, 7, 14, and 28 days, provided good net benefits at 20-100%, with the 7-day range being larger, providing good net benefits at 10-100% (Fig. 7A). Similar to the results in the training cohort, the clinical decision curves in the test cohort provided good net benefits in the 20-100% range for the 7-, 14-, and 28-day decision curves (Fig. 7B).

Fig. 7
figure 7

A. DCA curves for different survival time models in training cohort. B. DCA curves for different survival time models in test cohort

For elderly patients with A.baumannii BSI, which are insidious and difficult to detect after onset, the benefit of early intervention is higher, and the clinical benefit of a false-positive outcome is better than that of a false-negative. Our model showed positive net benefits for both the training and test cohorts at various risk thresholds of patient preference, with our model generating risks between 20% and 100%, enabling more effective identification of high-risk patients with always higher net gains compared to strategies that treat all patients. In the 10–25% risk region, our model is able to identify more high-risk patients than a strategy of treating all patients; in the greater than 25% risk region, the net benefit of our model is in the range of 5–10% overall, which corresponds to the identification of 5–10 true high-risk patients from 100 patients with no false positives, which are true high-risk patients for whom timely clinical intervention has a high clinical benefit.

Among the models at different time points, comparing the prognosis of death at 14 and 28 days post-infection, the model with a prognosis of death at 7 days post-infection had a higher clinical benefit for all interventions, which means that the model is more effective in identifying patients with a poor prognosis in the early stages of infection. In contrast, there was little difference in the identification and clinical benefit of the model for high-risk patients at different time points in the > 25% risk region. The results of the test cohort were similar to the training cohort.

Discussion

In this study, on the basis of a group of elderly patients with A. baumanniiBSI and different 28-day survival outcomes, we showed via univariate analysis that elevated indicators such as the SII, NLR, NPR, NPAR, CAR, and CLR, as well as reduced indicators such as CALLY and the LMR, were risk factors for death in elderly patients with A.baumannii sepsis or BSI. These new inflammatory indicators have become popular in recent years. Liu et al. [7] reported that the SII can be used to predict the prognosis of BSI effectively in combination with indicators such as rapid sequential organ failure assessment (qSOFA). Wu et al. used MATA analysis [8] and reported that the NLR is a reliable and valuable biomarker for predicting the prognosis and risk of death of adult patients with BSI. In addition, studies have reported that the CALLY index, NLR, LMR and other indicators can be used to identify BSI-critical patients with poor outcomes or predict the prognosis of BSI patients, which are closely related to the inflammation and immune response situation of the body and can predict the prognosis of BSIpatients [9,10,11]. However, few reports have been published on the prognostic value of these indicators in elderly patients with A. baumanniiBSI.

Multivariate Cox regression analysis revealed that an elevated NPR and CLR were independent risk factors for death in elderly patients with A. baumanniiBSI, and LASSO regression screening revealed that the model variables were the NPR and CLR, suggesting that an elevated NPR and CLR at the time of BSI were key predictors of the prognosis of elderly patients with A.baumanniiBSI in this study. The model established by NPR and CLR variables was well validated in the validation set, with an AUC value of not less than 0.870 in the post-infection prognosis, which enables timely and effective identification of high-risk patients, and timely intervention is expected to achieve a high clinical benefit.

The NPR is the ratio of peripheral blood neutrophils to platelets, and neutrophils are the “sentinel” of infection, which increases the levels of cytokines, such as granulocyte colony-stimulating factor (GCSF), and promotes the production and release of neutrophils [12]. Platelets are important mediators of hemostasis and thrombosis, and recent studies have shown [1314] that platelets contain a variety of immune receptors, such as Toll-like receptors, C-type lectin receptors, and nucleotide-binding oligomerization domain-like receptors, which activate immune cells to clear pathogens during infection, thus exerting anti-inflammatory effects. On the other hand, neutrophils can affect the function of platelets during inflammation through mechanisms such as the formation of neutrophil extracellular traps [1516], thereby affecting the course of inflammation in patients with BSI and thereby affecting the prognosis of patients, and a reduction in platelets during BSI increases the mortality rate of patients [17,18,19]. The NPR, as a marker for the dynamic interactions between neutrophils and platelets, is useful for understanding the inflammatory and immune dysregulation that occurs in elderly patients with A. baumanniiBSI, suggesting a good prognosis.

This study also revealed that an elevated CLR was strongly associated with death due to A. baumanniiBSI in elderly patients. Like the NPR, the CLR consists of the C-reactive protein/lymphocyte ratio, which is also used to assess inflammation and immune function. CRP is currently a widely used marker of inflammation in clinical practice, and studies have shown [2021] that patient mortality in patients with BSI is strongly correlated with CRP levels. Lymphocyte apoptosis plays a key role in the immunosuppressive phase of BSI. Jiang et al. reported that lymphopenia is an independent risk indicator for 28-day mortality in BSI patients, whereas long-term lymphopenia is a risk factor for mortality in elderly patients. On the other hand, compared with inflammatory markers such as PCT and IL6, CRP is a better marker for respiratory infection-induced BSI, whereas in elderly patients, the prevalence of COPD and pneumonia diseases is high [2223], and respiratory infection is one of the most important pathogens of BSI secondary to A. baumannii [2425]. Thus, combining these two aspects, an elevated CLR is a high-risk factor for poor prognosis of A. baumanniiBSI in elderly patients in this study.

In summary, two indicators, the NPR and CLR, respond to the body’s inflammation level and provide comprehensive information on immune function, and the NPR and CLR are considered indicators of inflammatory prognostic factors affecting COVID-19, nephritis, endocarditis and other inflammatory diseases [26,27,28]. The NPR also has a certain value in the diagnosis of septic infections [29], but current research on the associations between the NPR and the CLR and the prognosis of BSI is limited. In our study, elderly patients had unique clinical characteristics after A. baumanniiBSI infection due to their unique immune status as well as comorbid underlying diseases, and the NPR and CLR became noteworthy independent risk predictors of 28-day mortality in BSI patients. the results also show that the combined markers NPR and CLR are important markers of prognosis in elderly A. baumanniiBSI patients.

However, at the same time, we must recognize some limitations of this study. First, the study population is a single-region multicentre patient, which may not be representative of a wider and more regional population due to the number of cases as well as patient admissions, which may be affected by patient admissions, information bias, etc. Secondly, we are a regression study, and it needs to be further observed that improvement of some of the model variables can have the effect of improving the prognosis. In the next step, we should strive to externally validate our model in different populations and environments, integrating new predictors or biomarkers on the basis of the existing results can improve the predictive accuracy of the model, and combining with the NLR, CLR data for follow-up observation. On the other hand, we will select appropriate patients for timely correction based on the model indicators to further validate the reliability and accuracy of the model.

Conclusion

In conclusion, A.baumannii bacteremia remains an important clinical problem due to its high morbidity and mortality, especially in some elderly individuals with multiple comorbid underlying conditions, and understanding the prognostic risk factors for infection in these individuals is essential for improving patient care and prognosis. In our study, the NPR and CLR were closely associated with the prognosis of A. baumanniiBSI in elderly patients. Enhanced monitoring of the NPR and CLR can help physicians better assess the prognosis of A. baumanniiBSI in elderly patients and develop more effective treatment regimens to improve patient survival.

Data availability

The data used in this study are available from the corresponding author upon reasonable request.

References

  1. da Silva NCZ, da Rocha JA, do Valle. FM,etal.The impact of aging on the incidence and mortality rate of bloodstream infection: A hospital-based case-cohort study in a tertiary public hospital of Brazil[J]. Trop Med Int Health. 2021;26(10):1276–84. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/tmi.13650.

    Article  PubMed  Google Scholar 

  2. Cristina ML, Alicino C, Sartini M, et al. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area. J INFECT PUBLIC HEAL. 2017;11(2):171–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jiph.2017.06.003.

    Article  Google Scholar 

  3. China Antimicrobial Resistance Surveillance System. Antimicrobial resistance of clinically isolated bacteria from elderly patients:surveillance report from China antimicrobial resistance surveillance system in 2014–2019. Chin J Infect Control. 2021;20(2):112–23. https://doiorg.publicaciones.saludcastillayleon.es/10.12138/j.issn.1671-9638.20216171.

    Article  Google Scholar 

  4. Jiawei CHEN, Yingchun XU, Dawei TONG, et al. Changing antimicrobial resistance profiles of acinetobacter strains in hospitals across China: results from CHINET antimicrobial resistance surveillance program, 2015–2021. Chin J Infect Chemother. 2023;23(6):734–42. https://doiorg.publicaciones.saludcastillayleon.es/10.16718/j.1009-7708.2023.06.011.

    Article  Google Scholar 

  5. Hu F, Yuan L, Yang Y, et al. A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET). Front Cell Infect Microbiol. 2022;12:1075185. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fcimb.2022.1075185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ye XUE, Chao-shi ZOU,LI, Tai-jie et al. Risk factors and mortality for carbapenem-resistant Acinetobacter baumannii bloodstream infection in elderly patients: a 10-year retrospective study[J].Chin JInfect Control.2024;23(2):155–161. https://doiorg.publicaciones.saludcastillayleon.es/10.12138/j.issn.1671-9638.20244755

  7. LiuC, Wu X, Deng R, et al. Systemic immune-inflammation index combined with quick sequential organ failure assessment score for predicting mortality in sepsis patients. Heliyon. 2023;9(9):e19526. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.heliyon.2023.e19526.

    Article  Google Scholar 

  8. WuH, Cao T, Ji T, et al. Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis. Front Immunol. 2024;15:1336456. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fimmu.2024.1336456.

    Article  CAS  Google Scholar 

  9. Zhang J, Zhao Q, Liu S, et al. Clinical predictive value of the CRP-albumin-lymphocyte index for prognosis of critically ill patients with sepsis in intensive care unit: a retrospective single-center observational study. Front Public Health. 2024;12:1395134. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fpubh.2024.1395134.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kriplani A, Pandit S, Chawla A, et al. Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithotomy (PNL). UROLITHIASIS. 2022;50(3):341–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00240-022-01319-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. ChawlaA KA et al. PanditS,. Neutrophil-Lymphocyte Ratio (NLR), Platelet-Lymphocyte Ratio (PLR) and Lymphocyte-Monocyte Ratio (LMR) in predicting Systemic Inflammatory Response Syndrome (SIRS) and sepsis after Percutaneous Nephrolithotomy (PNL) EUR UROL. 2022;81:S68. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/s0302-2838(22)00135-x.

  12. Farkas JD. The complete blood count to diagnose septic shock. J Thorac Dis. 2020;12(Suppl 1):S16. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd.2019.12.63.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Portier I, Campbell RA. Role of platelets in detection and regulation of infection. ArteriosclerThrombVasc Biol. 2021;41(1):70–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1161/ATVBAHA.120.314645.

    Article  CAS  Google Scholar 

  14. Trivigno SMG, Guidetti GF, Barbieri SS, et al. Blood platelets in infection: the multiple roles of the platelet signaling machinery. Int J Mol Sci. 2023;24(8):7462. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/ijms24087462.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Guy A, GarciaG, Gourdou-LatyszenokV, et al. Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms. J THROMB HAEMOST. 2023;22(1):172–87. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jtha.2023.08.028.

    Article  CAS  PubMed  Google Scholar 

  16. AnsariJ, Gavins FNE. Neutrophils and platelets: immune soldiers fighting together in stroke pathophysiology. Biomedicines. 2021;9(12):1945. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/biomedicines9121945.

    Article  CAS  PubMed  Google Scholar 

  17. GuC WH, Li Y, et al. Construction and verification of a nomogram of factors influencing the risk of death in patient with sepsis-associated thrombocytopenia. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024;36(2):131–6. https://doiorg.publicaciones.saludcastillayleon.es/10.3760/cma.j.cn121430-20230421-00307.

    Article  Google Scholar 

  18. McDonaldB DM. Platelets and intravascular immunity: guardians of the vascular space during bloodstream infections and sepsis. Front Immunol. 2019;10:2400. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fimmu.2019.02400.

    Article  CAS  Google Scholar 

  19. Tacconelli E, Göpel S, Gladstone BP, et al. Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalized adults with bloodstream infections: a multicenter, prospective, cohort study. LANCET INFECT DIS. 2022;22(5):731–41. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S1473-3099(21)00587-9.

    Article  PubMed  Google Scholar 

  20. Huang N, Chen J, Wei Y, et al. Multimarker approach using C-reactive protein, procalcitonin, neutrophil CD64 index for the prognosis of sepsis in intensive care unit: a retrospective cohort study. BMC Infect Dis. 2022;22(1):662. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12879-022-07650-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zhou X, Fu S, Wu Y, et al. C-reactive protein-to-albumin ratio as a biomarker in patients with sepsis: a novel LASSO-COX based prognostic nomogram. Sci Rep. 2023;13:15309. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41598-023-42601-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Katsaros K, Renieris G, Safarika A, et al. Heparin binding protein for the early diagnosis and prognosis of sepsis in the emergency department: the prompt multicenter study. Shock. 2022;57(4):518–25. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/SHK.0000000000001900.

    Article  CAS  PubMed  Google Scholar 

  23. Daniels JMA, Schoorl M, Snijders D, et al. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest. 2010;138:1108–15. https://doiorg.publicaciones.saludcastillayleon.es/10.1378/chest.09-2927.

    Article  CAS  PubMed  Google Scholar 

  24. Hilmar W, Michael B, Edmond MA, et al. Nosocomialbloodstream infections caused by acinetobacter species in unitedstates hospitals: clinical features, molecular epidemiology, andantimicrobial susceptibility. Clin Infect Dis. 2000;31:690–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1086/314040.

    Article  Google Scholar 

  25. Trottier V, Namias N, Pust DG, et al. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect (Larchmt). 2007;8:437–43. https://doiorg.publicaciones.saludcastillayleon.es/10.1089/sur.2006.029.

    Article  PubMed  Google Scholar 

  26. Liu P, Li P, Peng Z, et al. Predictive value of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-neutrophil ratio, and neutrophil-to-monocyte ratio in lupus nephritis. LUPUS. 2020;29(9):1031–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/0961203320929753.

    Article  CAS  PubMed  Google Scholar 

  27. Li Z, Gao Q, Ren Z, et al. Nomogram based on neutrophil-to-platelet ratio to predict in-hospital mortality in infective endocarditis. BIOMARK MED. 2021;15(14):1233–43. https://doiorg.publicaciones.saludcastillayleon.es/10.2217/bmm-2021-0085.

    Article  CAS  PubMed  Google Scholar 

  28. Liu A, Hammond R, Chan K, et al. Comparison of Lymphocyte-CRP ratio to conventional inflammatory markers for predicting clinical outcomes in COVID-19. J Pers Med. 2023;13(6):909. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/jpm13060909.

    Article  PubMed  PubMed Central  Google Scholar 

  29. ZhangY, PengW ZX. The prognostic value of the combined neutrophil-to-lymphocyte ratio (NLR) and neutrophil-to-platelet ratio (NPR) in sepsis. Sci Rep. 2024;14(1):15075. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41598-024-64469-8.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by the Health Commission of Guangdong Province (B2023181) and the Traditional Chinese Medicine Bureau of Guangdong Province (20231045).

Author information

Authors and Affiliations

Authors

Contributions

Shaoqin Lai and Xiaojun Li designed the study and drafted the manuscript. Xiaojun Li, Donghao Cai, Chuangchuang Mei and Zhihui Liang collected and analyzed the data. All the authors reviewed the manuscript. All the authors have read and approved the final manuscript.

Corresponding author

Correspondence to Xiaojun Li.

Ethics declarations

Ethical approval and consent to participate

The study was approved by the Hospital Ethics Committee and conducted according to the Declaration of Helsinki (Approved No. of ethics committee: Z202404-002-01). Theethics committee waived the requirement for informed consent because the study was retrospective in design.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lai, S., Li, X., Cai, D. et al. Prognostic value of NPR and CLR-based nomogram modeling in elderly patients with Acinetobacter baumannii bloodstream infection. BMC Geriatr 25, 234 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12877-025-05884-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12877-025-05884-y

Keywords